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http://www.biomedcentral.com/1472-6963/14/520RESEARCH ARTICLE Open AccessFrontline health workers as brokers: provider
perceptions, experiences and mitigating strategies
to improve access to essential medicines in
South Africa
Bvudzai Priscilla Magadzire1*, Ashwin Budden2, Kim Ward1,3, Roger Jeffery4 and David Sanders1Abstract
Background: Front-line health providers have a unique role as brokers (patient advocates) between the health
system and patients in ensuring access to medicines (ATM). ATM is a fundamental component of health systems.
This paper examines in a South African context supply- and demand- ATM barriers from the provider perspective
using a five dimensional framework: availability (fit between existing resources and clients’ needs); accessibility
(fit between physical location of healthcare and location of clients); accommodation (fit between the organisation
of services and clients’ practical circumstances); acceptability (fit between clients’ and providers’ mutual expectations
and appropriateness of care) and affordability (fit between cost of care and ability to pay).
Methods: This cross-sectional, qualitative study uses semi-structured interviews with nurses, pharmacy personnel
and doctors. Thirty-six providers were purposively recruited from six public sector Community Health Centres in
two districts in the Eastern Cape Province representing both rural and urban settings. Content analysis combined
structured coding and grounded theory approaches. Finally, the five dimensional framework was applied to
illustrate the interconnected facets of the issue.
Results: Factors perceived to affect ATM were identified. Availability of medicines was hampered by logistical
bottlenecks in the medicines supply chain; poor public transport networks affected accessibility. Organization of
disease programmes meshed poorly with the needs of patients with comorbidities and circular migrants who move
between provinces searching for economic opportunities, proximity to services such as social grants and shopping
centres influenced where patients obtain medicines. Acceptability was affected by, for example, HIV related stigma
leading patients to seek distant services. Travel costs exacerbated by the interplay of several ATM barriers influenced
affordability. Providers play a brokerage role by adopting flexible prescribing and dispensing for ‘stable’ patients and
aligning clinic and social grant appointments to minimise clients’ routine costs. Occasionally they reported assisting
patients with transport money.
Conclusion: All five ATM barriers are important and they interact in complex ways. Context-sensitive responses
which minimise treatment interruption are needed. While broad-based changes encompassing all disease programmes
to improve ATM are needed, a beginning could be to assess the appropriateness, feasibility and sustainability of existing
brokerage mechanisms.
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South Africa is in the midst of a profound health transi-
tion that is characterised by a multiple burden of disease
that includes communicable and non-communicable dis-
eases [1]. This has increased demand for essential medi-
cines in the public health system which caters for almost
70% of the country’s population [2]. The South African
health system is plagued by a human resources crisis
and the primary health care system is a mainly nurse-
driven service [3]. Nurses together with other frontline
health providers (hereinafter referred to as providers) i.e.
pharmacy personnel (pharmacist or pharmacist assist-
ant) and doctors where present, play a strategic and key
role as brokers (usually as patient advocates) between
patients and the health system at the point of care.
Thus, understanding their perspectives and actions can
strengthen planning and provision of future services
[4]. We draw on the work of Long et al. in analysing
the role of brokers and their capacity to link disparate
groups in the provision of health care [5].
We explore the brokerage aspect in ATM, a funda-
mental component of health systems. Although no uni-
versal definition of access exists [6], for our purposes,
we adopt a definition which describes access as the fit
between supply and demand of healthcare along five di-
mensions: availability (fit between existing resources
and clients’ needs); accessibility (fit between physical loca-
tion of healthcare and location of clients); accommodation
(fit between the organisation of services and clients’ prac-
tical circumstances); acceptability (fit between clients’ and
providers’ mutual expectations and appropriateness of
care) and affordability (fit between cost of care and ability
to pay) [7].
Many studies in South Africa highlight supply- and
demand-side barriers to ATM such as treatment-related
costs [8-10], waiting times at health sites [11], poor
provider-patient interaction [12,13], and structural in-
equities, particularly among rural populations [14]. Most
of these findings derive from patient reports. In this
study, however, we explore provider perspectives, within
the same framework commonly utilised to understand
patient perspectives, to ascertain their perceptions of
these barriers to accessing essential medicines, i.e. those
medicines that satisfy the priority health care needs of
the population [15]. The literature on providers and
their interactions with patients tends to cast them in a
negative light [16-19]. However, little attempt has been
made to investigate how providers view and attempt to
mitigate the daily challenges they encounter in patient
care. The objective of this paper is to address this gap by
highlighting the views of primary health care providers
on supply- and demand-related ATM barriers in the
Eastern Cape Province. A second objective is to high-
light the ad hoc, empathic responses that providers intheir broker capacity employ in their day-to-day practise
to mitigate challenges faced by patients.Methods
Study setting
The Eastern Cape Province has an estimated population
of 6.8 million, contributing about 13.5% of the country’s
population [20]. 62% of its population is rural and highly
deprived, contributing significantly to poor health out-
comes [14]. At the time of the study, primary level
facilities were managed by two local authorities, the
Provincial Department of Health (responsible for the
majority of sites) and municipalities in urban areas.
However our sample consisted of only the Provincial
Department of Health sites.Design
This research is a component of a larger research pro-
ject on Accessing Medicines in Africa and South Asia
(AMASA), which investigated supply and access to
essential medicines for TB, HIV, Type-2 diabetes and uni-
polar depression. The present cross-sectional, qualitative
study is based on key informant interviews with nurses
(health centre managers also commonly known as facility
managers and disease programme managers), doctors and
pharmacy personnel (pharmacists or pharmacist assistants
or dispensing nurses). Thirty-six providers were purposively
recruited from six public sector Community Health Cen-
tres (CHCs) in two districts (one rural and one urban) in
the Eastern Cape Province. CHCs were selected because
they are the first level of care in the health system and pro-
vide a broad range of essential medicines and primary
health care services in the public system. Recruitment of
respondents from rural and urban settings aimed to con-
sider varying conditions of access in different geographic
locations. Four of the sites were rural and two were urban.
Key informant interviews addressed themes regarding ac-
cess to selected essential medicines which are available in
the public sector: lamivudine (3-TC), part of the first line
anti-retroviral therapy (ART) for adults infected by Human
Immunodeficiency Virus (HIV); rifampicin, an antimyco-
baterial drug for tuberculosis (TB); metformin, a blood
glucose lowering drug for type 2 diabetes; and two antide-
pressants, fluoxetine and amitriptyline. At each CHC, the
facility manager, pharmacy personnel and one or more
representatives per essential medicine (nurse and/or doc-
tor) were recruited. Unlike in towns where providers
manage a single disease programme, in rural areas, they
manage multiple disease programmes because of human
resource shortages. Sufficiency of sample size was deter-
mined by saturation, i.e., when the collection of new
data did not shed any further light on the issue under
investigation.
Table 1 Characteristics of respondents N(36)
Antiretroviral Therapy (ART) programme nurses 7
Tuberculosis (TB) programme nurses 6
Chronic care nurses (responsible for management
of diabetes and/or mental health programmes)
8
Doctors 3
Pharmacist/pharmacist assistant/dispensing nurses 6
Facility/health centre managers (nurses) 6
Sex
Male 6
Female 30
Age (years) Range: 24-63
Median: 52
Number of years working at the facility Range: <1-29
Median: 8
Number of years working in the health profession Range: <1-30
Median: 26
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March and April of 2012. This study protocol was ap-
proved by the University of the Western Cape Ethics
Committee and both the National and Provincial De-
partment of Health Committees. Each participant gave
both verbal and written consent to participate in the
research and was given information leaflets with a
brief description of the study and contact details of
the responsible institution and contact person.
Instruments
Key informant interviews with providers were con-
ducted using a semi-structured interview guide. Inter-
view guides for each stakeholder group contained a set
of broader themes with corresponding questions and
probes as informed by the study objectives. However,
the common lines of enquiry among all stakeholder
groups that were relevant for this paper focussed on
identifying the most significant health system and pa-
tient level barriers to accessing essential medicines
and how these differ or are similar across settings
(rural and urban); type of medicine (or disease condi-
tion); and the strategies that exist within the health
system to overcome these barriers, including the avail-
ability of alternative medicines access points such as
mobile clinics. Key informant interviews were digitally
recorded and transcribed.
Data analysis
The transcripts were imported to a computer programme,
MAXQDA version 10 for organisation and content analysis.
Content analysis is a standard approach to analysing quali-
tative data to identify patterns, themes and biases in that
material [21]. The analysis applied structured coding and
grounded theory approaches to the narratives. Coded seg-
ments of transcripts were then retrieved and further ana-
lysed for recurrent or conflicting response patterns. Finally,
coded segments were categorised according to the five
dimensional framework. The coding frameworks were dis-
cussed with the authorship team at both stages.
Results
The sample and background characteristics of respon-
dents are shown in Table 1 below.
Various supply- and demand-side barriers to essential
medicine access were identified.
Providers also discussed the ad hoc strategies that they
employ to address these challenges. Notably, although
the investigation aimed to consider essential medicines
for HIV, TB, diabetes and depression, we found minimal
prescribing of antidepressants in this context. When pre-
scribed, it is usually on a short term basis. However, we
still included the findings with regard to antidepressants
in the analysis. Below we elaborate provider perspectiveswith reference to the five dimensional framework and
their mitigating strategies and recommendations.
Availability
Stock outs (i.e. when health centres run out of medi-
cines) were viewed, as a major challenge particularly in
rural clinics. Providers in rural CHCs highlighted the
lack of dedicated vehicles to transport medicines from
CHCs that act as temporary storage for rural clinics as a
hindrance to efficient distribution. Each of the four rural
CHCs visited provided temporary medicine storage for
more than 20 peripheral clinics located in the deep rural
areas. However, at the time of the research there were
no dedicated vehicles for transportation of medicines
from the CHCs to the clinics. Vehicles allocated for
other tasks were also expected to deliver medicines. In
the past, medicines delivery was outsourced to a private
company by the Provincial Department of Health, how-
ever, the contract with the service provider had expired
(reportedly a couple of months before our research) and
no other strategy had been put in place to address deliv-
ery of medicines more sustainably. As one health centre
manager explained,
“There is no challenge getting the drugs from the depot
to here, the challenge is getting the drugs from here to
the clinics because we have shortage of transport. All
our vans are attached to programmes. They are used
by mobile clinics, school health, circumcision so when
there is a need for the clinics to get some drugs we
have to borrow a van from that person. And the clinics
are so many. We are having 18 clinics at the moment
and they will soon be 22. We are short of vehicles
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dedicated vehicle. The one that they are using, we used
to take it when there is gas, it’s the only long base van so
when we have to deliver gas to the clinics we need that
van and when we need to deliver medication then you
have to borrow”. (Facility manager, CHC 1, rural)
In the event of stock outs, providers reported that they
either referred patients to alternative facilities or gave
them another appointment date to return to the facility.
Erratic supplies were reportedly one of the main factors
leading to patients’ loss of confidence in local clinics. At
one of the urban CHCs, it was reported that pharmacy
personnel had conducted a study to determine the
amount of money spent on travel to facilities and the
number of taxis taken per trip. Their investigation found
that 60% of patients on ART lived outside the catchment
area and generally took up to two taxis to reach the
CHC. Among the reasons for not attending the nearest
clinic, stock outs and perceived quality of service ranked
highly. Accounts from TB and ART programme nurses
corroborate this finding:
“We refer them to the local clinics but they come
back because there is a shortage of treatment in the
local clinics…we cannot chase them away because we
know they need to take this treatment”. (TB nurse,
CHC6, urban)
“We have got so many facilities around here and they
(patients) don’t want to go to those clinics even though
they are only walking distance…Sometimes they say
there are no drugs there…we are still trying to
investigate because we are always told that drugs are
being taken to the clinic, how come the patients say
there are no drugs?” (ART nurse, CHC 2, rural)
Accessibility
Key informants agreed that public transport to periph-
eral clinics, which public sector patients rely on heavily,
is either absent or limited. According to providers, the
district boundaries in rural locations, in particular, are
out of sync with public transport networks. As a result
patients opt for CHCs in town which are more access-
ible and safer to visit. The following accounts illustrate
this point:
“There is a challenge because this CHC is very far
from other clients. Now the problem is there are
residential clinics (small, rural clinics) and the client
will give the report that there is no transport from my
area to the clinic so I only get the transport from my
area to town so in the morning it’s better to come to
town, whereas they don’t belong to this catchmentarea, they belong to residential clinics…in the morning
transport is going to town, maybe a bus or a van and
you will find that they will be short of money and they
will come after their old age pension grant and miss
their appointment. We are having that problem with
clients far away from us but we do register them because
we don’t know what to do. We do accept them with their
problem we give them the return date three days before
the treatment is finished so that there is a buffer in case
they are late”. (ART nurse, CHC1, rural)
“…we are not only serving this area, our so called
catchment, they (patients) say to us it’s better to take a
taxi to come here than to go to the rural clinics
because in the morning, transport wise it’s not very
easy and with other localities they don’t have
transport. They are afraid of being raped, so they
prefer taking a taxi for twenty rand (approximately
two United States dollars at time of research) to come
to East London, and mind that is dependent maybe on
the mother to get the money to come here”. (Chronic
care nurse, CHC5, urban)
Lack of transport is largely attributed to poor infra-
structure and is the reason for transport operators avoid-
ing certain routes. The following sentiments were captured
regarding difficulties for patients in the Transkei region,
a former homeland and a deeply deprived area in the
province:
“… our roads are still not tarred, so some patients
have to travel more than 50 km. You know 50 km in
the rural areas is a lot, they can even take up to two
hours because of the gravel roads…and in the rural
areas by 5 p.m. the transport gets finished, so these
people won’t have transport to go back home. Some of
the patients have to wake up at 3 a.m. when they
come to visit the clinic, like for reviews…it’s not fair”.
(Chief medical officer, CHC3, rural)
Accommodation
The down referral program which transfers patients to
facilities nearest to their homes was implemented as a
national strategy to improve ATM. There were mixed
opinions about the success of down referral but there
was consensus that uptake of services at the lower levels
of care could increase if the quality of services, including
the availability of medicines improved. Here accommo-
dation of patient perceptions play a key role in the
uptake of the intervention as illustrated below:
“People want to go to a place where there is a doctor,
where there is availability of medicines. Even if they
are not going to be seen by that doctor…as long as
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you to be seen by the doctor, the doctor will be there.
There are people who don’t want to go to clinics on
that basis; they know there are nurses only”.
(Pharmacist, CHC6, urban)
“…with the municipal clinics for example, they don’t
have a doctor every day, they don’t have an x-ray
machine, and they have certain days for immunization,
for minor ailments, for chronics for example. Now here…
you can come any day for immunization, you can come
any time…and I think that is one of the reasons why
they flock here. We’ve got many doctors, we’ve got six
permanent doctors…they want a doctor, they want an
x-ray, they want to come whenever they want to come”.
(TB nurse, CHC5, urban)
“We do transfer them (patients) to the local nearest
clinic, but sometimes they don’t want to go there, they
prefer to come here, they don’t get the treatment at the
nearest clinic, they say the treatment was out of stock
so they decided to come here, but we are trying to take
(refer) them back to the nearest clinic so they can
afford money-wise”. (Facility manager, CHC1, rural)
“We are doing down referrals to the near sites but it’s
not proper because patients are going there in those
clinics and they say they didn’t get their medication”.
(ART nurse, CHC4, rural)
In the context of working with the poor, proximity of
health services to social services emerged as important
because social grants are central to poor people’s liveli-
hoods. Many informants associated patients’ choice of a
health care facility with its closeness to other services
such as social grant collection points and shopping cen-
tres. Providers reported that many patients rely on their
or a family member’s social grant to cover transport ex-
penses. This was confirmed by the research team when a
particular facility waiting area was relatively empty on
the day of grant collection compared to other days. The
ability to combine medicine collection appointments
with other personal business made it more appealing as
indicated by the following accounts:
“There are some clinics in other rural areas, but they
say this is their town, Home Affairs is here, Social
Development is here, Shoprite [supermarket] is here, so
they say they will rather come to town, so they do
everything and then come to the clinic”. (TB nurse,
CHC4, rural)
“We have got eleven communities that we are serving.
They are very far from here, it’s more than 30 km…theyare rural and they are struggling to come here, others
are not getting any grant and they don’t have any
money to come”. (Chronic care nurse, CHC4, rural)
Another important aspect in the organisation of dis-
ease control programmes is their inability to recognise
that circular migration is a key feature among patients.
Circular migrants are people who move between their
places of origin to nearby urban centres or to other
provinces in search of economic opportunities or for so-
cial reasons. For example, many people from the Eastern
Cape Province move to the Western Cape Province
seeking for economic opportunities and they travel be-
tween those provinces regularly. The provinces in some
cases use different treatment protocols and this confuses
not only the patients, most of whom recognise their
medication by its physical appearance rather than gen-
eric names, but also providers, who feel overwhelmed by
such scenarios as indicated by two nurses in rural
settings.
“In the Western Cape they have their own regimen,
which is not the same as ours here because even for
transfers, we always have that problem because we many
not know that regimen. You will find that the drug that
is in our regimen two, they are using it for regimen one.
Now that is confusing”. (TB nurse, CHC2, rural)
“Our concern is for people coming from KZN (Kwa-Zulu
Natal province) who are on ATRIPLA (fixed-dose ART),
that is one tablet and we are still using three separate
drugs”. (ART nurse, CHC1, rural)
In some cases, patients travel without referral letters
and as a result default on their treatment because they
are apprehensive about going to the health centre without
a referral letter. They delay seeking medical attention until
they become seriously ill. The following narratives echo
this point.
“With diabetes and hypertension, patients will say I
was in Cape Town to see my sick child, and we will
ask them but why didn’t you carry your own clinic
card, what about your own health?” (Chief medical
officer, CHC3 rural)
“…we tell them if you have to go somewhere come and
report so that we provide extra medicine supply and if
you are staying for a longer period then take the transfer
letter. They don’t come and report and they don’t take
their transfer letters. When they reach KZN, they are
expecting the client to have the transfer letter so that
they know exactly what is going on with him or her.
Even if you trace by phone she says oh I am taking the
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collect your medication and your transfer letter but they
say no they are giving me. But then when she comes in
two months later the card is still with that last date
when she came here”. (TB nurse, CHC2, rural)
“…they will tell you they have been to Cape Town but
they don’t come with a card from Cape Town so we
don’t know if they have taken the treatment or not”.
(Chronic care nurse, CHC3 rural)
“The patients are moving up and down that is why
they are not adhering”. (ART nurse, CHC2, rural)
Acceptability
Socio-cultural influences were also highlighted as fuelling
stigma and the reason for some ART patients choosing to
go to facilities that are further away from their homes, ra-
ther than nearer facilities. This was common among HIV
patients and was not reported for other conditions. These
three illustrations highlight this situation:
“…they (ART patients) are not happy about being seen
taking HIV treatment in their clinics…if one persists,
you observe and if you find out that they might end
up not taking the treatment, we admit that one”.
(Facility manager, CHC4, rural)
“They stigmatise this condition (HIV) and we need to
educate the people. I have got a brother who is HIV
positive. I didn’t know he was HIV positive until
today…he has been getting treatment from an NGO in
town. Now that NGO has closed because of financial
issues, now they are referred to the hospital. I don’t
know whether he is running away from me or the
centre itself”. (Facility manager, CHC6, urban)
“We have a patient that comes once a month; she’s an
HIV positive lady and had TB also. She comes here …
for her treatment. So patients will go where they want
to go even if you made hundred packs to leave at the
(local) clinic, they won’t go there. She spends five
hundred rand (approximately 56 United States dollars
at the time of research) to come here when it’s time for
her checkup. When it’s not her checkup, her son comes
but because she had TB she had to come two weekly
you know but with the ARV, her son collects her ARVs.
ARV’s are expiring in other clinics because they don’t
want to go to there… That’s why we have an overflow
of patients here”. (TB nurse, CHC5, urban)
Affordability
Although essential medicines are available free of charge
in the public sector, unaffordable transport costs wereidentified as a cross-cutting theme. In some instances
patients could not afford to pay for transport to the
nearest facility because of poverty. However, many other
times, their circumstances were exacerbated by barriers
identified under other dimensions of availability, accessi-
bility, accommodation and acceptability. Differences in
how medicines are distributed within various disease
control programmes were viewed as an influence on
the cost of accessing medicines i.e. ART availability in
strictly accredited facilities poses a challenge for patients
who have to travel longer distances because the nearest
clinic does not offer ART. TB patients are among those
who face the biggest transport challenges during their
treatment period as they are required to make daily or
weekly visits to the facility for their medicines. A TB
nurse in East London estimated that some patients com-
ing from afar pay approximately R60 (approximately
seven United States dollars at the time of research) a day
on transport and this was contributing to the defaulting
rates.
Empathic provider responses to address ATM barriers
The providers’ perspectives highlight the inadequacy of
the existing formal responses in addressing many of the
circumstances that impinge on equitable ATM. In con-
fronting these challenges in their daily provision of care,
providers adopt ad hoc decisions to meet the needs of
their patients. There was agreement that because of
patients’ low incomes and dependence on social grants,
household savings are almost depleted before their next
clinic appointment. Some providers attempted to align
clinic appointments with social grant collection dates
so that patients can collect their medicines and social
grants on the same day. Others highlighted that this was
helpful for the patients but it was impractical with large
numbers of patients as it would create an imbalance in
patient load and insufficient health personnel to deal
with patients on the busier days.
In other cases, providers reported that they assessed
the patient profile and provided what they termed ‘buf-
fer’ stock for a few additional days (usually less than
one week) in case patients come late for their appoint-
ment. In most cases, however, providers dispensed
medicines for longer than the stipulated policy to pa-
tients they deemed stable, but cautioned them to re-
turn to the facility if they felt the need for medical
attention before their next scheduled appointment.
This was at the discretion of the prescriber, usually the
nurse. There were variations in terms of how much
stock patients received but between two weeks and a
month were common for TB treatment that would
otherwise be collected daily and two to three months
for HIV and diabetes treatment which would otherwise
be collected monthly. Although the decisions were
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personnel were aware of this practice and supported it
as highlighted below:
“The sister in the chronic[care department] has now
developed a system of giving the treatment to those
that are stable…she must give them for three months
…and then the fourth month they come for
observations but those who are unreliable they must
come monthly”. (Facility manager, CHC4, rural)
“We do have those that are adhering so we give them
their monthly supply. And because …they don’t want
to use their (local) clinics, they come here and it is
very far”. (TB nurse, CHC2, rural)
Occasionally, providers reported assisting desperate
patients with their personal finances to enable them to
return to their homes. An illustration that was given by
a nurse in an urban facility:
“…really we are stuck at times here with the patient,
you will have to take your money, give patients to take
taxis to their respective areas, because they are stuck
here, maybe they are taken by the ambulance at
night…there’s no money, there’s no escort, so you have
to see to the finish. It is not easy to be a nurse, and
when you look at us here, we are in an urban setting,
think about the nurse who is working in the rural
area; it is very much more difficult”. (Chronic care
nurse, CHC5, urban)
Provider views on future strategies to improve ATM
Providers described strategies that could be employed in
the future to address poor quality of services in rural
clinics, for example, having more sites accredited for
ART or use of non-accredited sites merely as medicine
collection sites and incentivizing doctors to work in
rural sites so that staffing levels can be improved. One
doctor indicated that she was the only doctor working at
27 clinics and this gave her an unreasonable work load.
At the time of the research there was anticipation of a
shift toward having all sites in the province managed by
the Provincial Department of Health including those
previously managed by the municipality. There was
agreement that this move would improve coordination
in the delivery of services and even resource sharing as
indicated by one respondent:
“…there was no cooperation between us and the
municipality; it is going to be better now. Even if there
is a shortage in a particular clinic, if I am here as a
manager, I could allocate my nurses to that clinic”.
(Facility manager, CHC6, urban)We enquired about the potential role of mobile clinics
in improving distribution of medicines although none of
our tracer medicines had been distributed through the
mobile clinics. Providers felt that mobile services have
been geared toward dealing with minor ailments and as
a result patients with comorbidities collect part of their
medication from the mobile clinic and additionally, have
to travel to the facility to collect their chronic medicines.
This results in patients abandoning the mobile clinic
completely and going to the facility where they can
collect all their medicines simultaneously.
At an operational level, mobile clinics have been pla-
gued by many challenges such as unavailability of vehi-
cles committed to this service, bad roads and weather
conditions which hinder physical accessibility and short-
ages of staff at the facility level which results in commu-
nity appointments being cancelled as highlighted by
these respondents:
“Our staff shortages mainly affect the mobile services
where we only have two professional nurses and one
nursing assistant. According to the organogram, we are
supposed to have two teams with five professional
nurses”. (Facility manager, CHC2, rural)
“…at times they (service providers) have transport
challenges so they will be disappointing those patients.
They used to wait a long time, so they decided not to
wait for the mobile clinic, they decided to come and
get their treatment here. So if the mobile is not coming
if that appointment date is cut, they wait there
because of the transport problems”. In addition,
“…sometimes they (patients) used to say we are not
getting all the treatment, others are out of stock, so
they do come (to the CHC) for other treatment”.
(Chronic care nurse, CHC3, rural)
Issues pertaining to resources might be easier to ad-
dress but addressing the needs of patients with comor-
bidities remains a challenge in areas where mobile
clinics are not a supplementary service to the local clinic
but are the only available means of service nearest to the
people. While it is acknowledged that mobile clinics
have the potential to address access barriers in hard to
reach areas, some providers were sceptical about provid-
ing medicines such as ART through the mobile clinic
citing intense administrative procedures associated with
ART programmes, potential lack of privacy and limited
contact time between patients and providers as the
mobile vans move to different locations.
Discussion
Our findings emphasize the role of providers as health-
care brokers with respect to their creative responses in
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shortfall. A key benefit of this study was the ability to
draw experiences across different essential medicines in
both urban and rural settings and with providers who
have different roles in the care pathway. The reported
perspectives were largely shared across providers of dif-
ferent essential medicines. Our key informant interviews
highlight important bottlenecks and system failures that
correspond to the multiple dimensions of access [7] and
the practical dilemmas that providers face in dealing
with them. Providers are directly impacted by these chal-
lenges on the frontline of care and this study highlights
the proactive strategies that they employ to ensure that
patients obtain and remain on treatment. How providers
enact the role of broker between the system and their
patients is critical to consider in terms of the broader
problem of medicine accessibility and health services
in general. There is a need for broad-based changes
encompassing all disease areas to improve ATM. In
doing so, however, there is a need to take into account
three tiers of brokerage: (i) ATM barriers with no solu-
tions offered yet (e.g. bottlenecks in the medicines sup-
ply chain and socio-economic and cultural factors), (ii)
ATM barriers with potential solutions outside the health
providers’ power (e.g. building improved transport net-
works) and (iii) ATM barriers with solutions already
being implemented (e.g. flexibilities in prescribing and
dispensing to suit patient needs). Implications for prac-
tice are discussed through presentation of a number of
mechanisms with a set of critical questions to ask when
addressing ATM.
First, the medicines supply chain is undermined by
severe resource constraints and structural weaknesses
often leading to stock outs and provision of inferior ser-
vices. Patients respond to system barriers by ‘shopping’
for better services within the system or with alternative
providers if they can afford the associated costs. Other-
wise, they give up [12]. Similar to another study in South
Africa [22], providers highlighted haphazard movement
of patients within the health system as one of the threats
to the down referral program. This emerged as a key fac-
tor that prohibits efficient planning related to medicines
supply at primary level facilities. The supply chain needs
to be equipped to deal with the growing demand for
consistent supply of medicines, especially chronic medi-
cines and this involves proper planning at all levels.
Second, context and patient characteristics play an im-
portant role in provision of medicines. For example, cir-
cular migration emerged as a key feature of the patient
population yet health services tend to assume that pa-
tients are permanently situated in a particular locus. As
a result, many patients are lost to follow up or default
on treatment when they temporarily migrate from one
place to the other. Also, relative to urban patients, ruralpatients face more access barriers as a result of poverty
and underdeveloped transport infrastructure. Peters and
colleagues found that the poor in low and middle income
countries (LMICs) are consistently at a disadvantage in
each of the dimensions of access and their determinants
[23]. Another South African study also highlighted the
financial burden of costs associated with health care on
patients [8]. Both supply- and demand-side barriers carry
a financial consequence for patients, particularly with re-
spect to transportation. For example, patients incur costs
for greater distances travelled in dealing with underdevel-
oped transport infrastructure or medicine stock outs in
more proximate clinics. Patients’ ability to afford health
related costs depend, among other things on any earnings,
the composition of the social grants that a household re-
ceives, the size of the household and the household prior-
ities. In light of this, improving access to medicines requires
engaging in intersectoral actions between health, welfare
and infrastructural development. Organization of “circular”
public transport, instead of only “centripetal” transport,
which gives users incentives to travel to town, instead of to
the local health centre, is required.
Implications for policy and practice
Findings from this study suggest that many providers are
aware of the existing barriers to accessing medicines.
They are taking advantage of the flexibilities within the
health system, which enables them to make critical, re-
sponsible and responsive decisions in practice. They are
attempting to address these challenges in creative and
empathic ways. Indeed, clinical empathy is a quality that
is deemed critical in determining patients’ ability to cope
with both illness and quality of care and to improve
health outcomes [24,25]. Our findings allude to the com-
mitment of providers and the important role that they
are playing in discovering the needs of the populations
they serve and the efforts to address them. This draws
attention to the social reality of relationships and inter-
actions occurring at the patient and provider level and
offers a different view to previous studies which found
this relationship to be largely negative [12,26]. It is
plausible that continuous patient-provider interaction, as
evidenced by the average of eight years that health pro-
viders work in the same facility, promotes nurturing of
positive relationships wherein providers better under-
stand the challenges that patients face.
However, the practice of prescribing and dispensing
for periods beyond what is lawfully allowed deserves
careful attention, given the consequent impact of less
frequent monitoring and patient follow-up. Providers
however, suggest that dispensing medicines to stable
patients with chronic conditions for up to six months
would help reduce travel costs and de-congest health
centres. They do not view this strategy as a threat to
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facility as needed. Although prescribers have devised
ways of evaluating patient stability through assessing
health outcomes over time, the standard differs from
place to place. The current variation in dispensing prac-
tices in order to address patient concerns raises import-
ant questions for policy and suggests a need to look into
whether there is merit in institutionalising the informal
strategies currently employed from an evidence-based
point of view. Recent studies report that with the right
kind of community support, it is feasible to provide
treatment for longer periods [11]. Also, a recent pro-
gram in South Africa has piloted provision of ART for
longer periods with good results [27]. In the absence of
standardised and evidence-based dispensing practices in
order to address patient monitoring, the informal strat-
egies reported in this paper may not produce optimum
patient therapeutic outcomes.
It is also worth noting, that the current strategies
employed by providers favour patients who are deemed
stable and might further discriminate against patients
who are unable to visit health centres because of mul-
tiple barriers. Diversification of strategies to improve
ATM is absolutely critical. Diversification involves look-
ing beyond the conventional facility-based approach by
considering, among others, community based models
which maintain identifiable links with the health system
to increase the trust of the users.
Finally, the emergence of chronic non-communicable
diseases and multiple morbidities is fast becoming the
rule rather than the exception and efforts to pre-engineer
the system towards a comprehensive, integrated, horizon-
tal primary health care system should be considered. For
instance, a recent analysis of mortality causes in South
Africa has highlighted more deaths resulting from non-
communicable diseases such as diabetes than from HIV
[28]. A responsive system takes into account the limita-
tions of a vertical system while at the same time ensuring
that medicines for priority conditions are not compro-
mised [29]. Responsiveness also requires taking into ac-
count characteristics of the population served to ensure
that circular migrants have continuous ATM and to ad-
dress other social, cultural and economic barriers more
appropriately. Ultimately, addressing these ATM barriers
creates a healthier working environment for providers and
protects them from situations where, for example, they
occasionally feel obligated to assist stranded patients.
Conclusion
Effective ATM to minimise treatment interruption re-
quires addressing supply- and demand- barriers concur-
rently with a consideration for context. The evidence
presented in this paper shows the importance of all five
access barriers (availability, accessibility, accommodation,acceptability and affordability) and the complex ways in
which they interact with each other. Issues that require
further research include diversifying methods for distrib-
uting medicines in rural settings, understanding whether
the brokerage mechanisms adopted by providers actually
improve ATM, and determining whether such practices
are appropriate, feasible and sustainable. It is also critical
to understand the characteristics of the population served
to ensure that circular migrants have continuous ATM.
Finally, the brokerage role of providers is underutilised
and we recommend that as ongoing practice, they should
be actively engaged in intersectoral discussions aimed at
improving the health care response.
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